Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPE/1707 stock hub

TPE/1707 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPE/1707is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.7B

Taiwan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPE/1707

In the news

Latest news · TPE/1707

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11.4

P25 12P50 15.5P75 22.5

Trailing P/E13.8

P25 14.4P50 18P75 31.9

ROE15.6

P25 -16.2P50 0.3P75 9.8

ROIC20.9

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPE/1707 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

243

Groups with data

Currency

TWD

Showing 243 of 243 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	501
Enterprise value	TWD 14.4B
Exchange	Taiwan Stock Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0001707008
Last refreshed	2026-05-10
Market cap	TWD 16.7B
Price	TWD 113
Price currency	TWD
Rev Per Employee	20,462,289.42x
Sector	Healthcare
Sic	2833
Symbol	tpe/1707
Website	https://www.grapeking.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	7.28%
EV Earnings	11.82x
EV/EBIT	6.64x
EV/EBITDA	5.34x
EV/FCF	8.3x
EV/Sales	1.4x
FCF yield	10.36%
Forward P/E	11.44x
P/B ratio	1.39x
P/E ratio	13.83x
P/S ratio	1.63x
PE Ratio10 Y	18.83x
PE Ratio3 Y	15.73x
PE Ratio5 Y	16.48x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	20.89%
EBITDA Margin	25.34%
FCF margin	16.92%
Gross margin	75.08%
Gross Profit	TWD 7.7B
Gross Profit Growth	-11.1%
Gross Profit Growth Q	-7.08%
Gross Profit Growth3 Y	-3.19%
Gross Profit Growth5 Y	0.42%
Net Income	TWD 1.2B
Net Income Growth	-15.88%
Net Income Growth Q	-0.44%
Net Income Growth Years	0%
Net Income Growth3 Y	-5.79%
Net Income Growth5 Y	-0.86%
Pretax Margin	22.41%
Profit Margin	11.88%
Profit Per Employee	TWD 2.4M
Profitable Years	20
ROA	8.62
Roa5y	10.11
ROCE	17.39
ROE	15.6
Roe5y	18.85
ROIC	20.88
Roic5y	27.71

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-1.87%
Cagr15y	9.95%
Cagr1y	-13.54%
Cagr20y	17.42%
Cagr3y	-10.87%
Cagr5y	-3.7%
Div CAGR10	0.7%
Div CAGR3	-4.55%
Div CAGR5	-1.28%
EPS Growth	-15.86
EPS Growth Q	-0.81
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-5.82
EPS Growth5 Y	-2.54
FCF Growth	38.83%
FCF Growth Q	-1.42%
FCF Growth3 Y	-11.52%
FCF Growth5 Y	2.87%
OCF Growth	16.2%
OCF Growth Q	-3.15%
OCF Growth10 Y	5.25%
OCF Growth3 Y	-10%
OCF Growth5 Y	-4.33%
Revenue Growth	-8.14x
Revenue Growth Q	-4.84x
Revenue Growth Years	0x
Revenue Growth3 Y	-0.45x
Revenue Growth5 Y	2.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.66
Assets	TWD 15.7B
Cash	TWD 4.3B
Current Assets	TWD 5.7B
Current Liabilities	TWD 3.4B
Debt	TWD 215M
Debt EBITDA	TWD 0.08
Debt Equity	TWD 0.02
Debt FCF	TWD 0.12
Equity	TWD 12.1B
Interest Coverage	457.5
Liabilities	TWD 3.7B
Long Term Assets	TWD 10.1B
Long Term Liabilities	TWD 250.7M
Net Cash	TWD 4.1B
Net Cash By Market Cap	TWD 24.27
Net Cash Growth	-4.88%
Net Debt EBITDA	TWD -1.56
Net Debt Equity	TWD -0.34
Net Debt FCF	TWD -2.34
Tangible Book Value	TWD 10.2B
Tangible Book Value Per Share	TWD 69.08
WACC	5.63

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.65
Inventory Turnover	2.85
Net Working Capital	TWD -2B
Quick ratio	1.36
Working Capital	TWD 2.2B
Working Capital Turnover	TWD 4.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.01%
Dividend Growth	-13.04%
Dividend Growth Years	0%
Dividend per share	TWD 6
Dividend Years	22
Dividend Yield	5.31%
Ex Div Date	2026-06-17
Last Dividend	TWD 3.8
Payout Frequency	Semi-Annual
Payout Ratio	73.44%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-17.23%
1Y total return	-13.53%
200-day SMA	124.7
3Y total return	-29.21%
50-day SMA	118.8
50-day SMA vs 200-day SMA	50under200
5Y total return	-17.17%
All Time High	282
All Time High Change	-59.93%
All Time High Date	2016-10-20
All Time Low	1.61
All Time Low Change	6,909.93%
All Time Low Date	2001-10-09
ATR	1.53
Beta	0.26
Beta1y	0.16
Beta2y	0.17
Ch YTD	-10.67
High	114
High52	139
High52 Date	2025-05-12
High52ch	-18.71%
Low	112.5
Low52	112
Low52 Date	2026-05-07
Low52ch	0.89%
Ma50ch	-4.9%
Price vs 200-day SMA	-9.36%
RSI	31
RSI Monthly	32.14
RSI Weekly	27.74
Sharpe ratio	-1.25x
Sortino ratio	-1.44
Total Return	5.32%
Tr YTD	-9.1
Tr15y	314.67%
Tr1m	-6.22%
Tr1w	0.89%
Tr3m	-7%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 2.1B
Operating Income Growth	-14.33
Operating Income Growth Q	-2.51
Operating Income Growth3 Y	-5.67
Operating Income Growth5 Y	-1.46
Operating margin	20.89

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	115,836,873%
Net Borrowing	-70,918,000
Shares Insiders	11.71%
Shares Institutions	18.31%
Shares Out	148,137,373
Shares Qo Q	0.9%
Shares Yo Y	-0.01%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 1.7B
Average Volume	227,597.15x
Bv Per Share	69.81
CAPEX	TWD -445.5M
Ch10y	-43.78
Ch15y	131.6
Ch1m	-6.22
Ch1w	0.89
Ch1y	-17.82
Ch20y	971.1
Ch3m	-7
Ch3y	-39.25
Ch5y	-34.49
Ch6m	-8.87
Change	0.44%
Change From Open	0.44
Close	112.5
Days Gap	0
Depreciation Amortization	456,199,000
Dollar Volume	16,023,400
Earnings Date	2026-05-13
EBIT	TWD 2.1B
EBITDA	TWD 2.6B
EPS	TWD 8.17
F Score	4
FCF	TWD 1.7B
FCF EV Yield	12.04x
FCF Per Share	TWD 11.71
Financing CF	-1,745,252,000
Fiscal Year End	December
Founded	1,969
Graham Number	113.28402
Graham Upside	0.25
Income Tax	TWD 436.8M
Investing CF	-606,258,000
Is Primary Listing	1
Last Earnings Date	2026-02-23
Last Report Date	2025-12-31
Last Split Date	2005-09-15
Last Split Type	Forward
Lynch Fair Value	TWD 40.85
Lynch Upside	-63.85
Ma150	123.4
Ma150ch	-8.43%
Ma20	115.8
Ma20ch	-2.38%
Net CF	-178,047,000
Next Earnings Date	2026-05-13
Open	112.5
P FCF Ratio	9.65
P OCF Ratio	7.68
Payment Date	2026-07-16
Position In Range	33.33
Ppne	8,075,902,000
Price Date	2026-05-08
Price EBITDA	TWD 6.44
Ptbv Ratio	1.64
Relative Volume	0.63x
Revenue	10,251,607,000x
Tax By Revenue	4.26x
Tax Rate	19.01%
Tr20y	2,381.95%
Tr6m	-7.26%
Volume	141,800
Z Score	5.03

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPE/1707 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.3%

$6.00 annual per share

Payout ratio

+73.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-1.3%

0 consecutive years of growth

Total shareholder yield

+5.3%

Next ex-dividend date: 2026-06-17

Performance

TPE/1707 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPE/1707?

Insider, institutional, and short-interest positioning.

Institutional ownership

+18.3%

Share of float held by funds and institutions

Insider ownership

+11.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

TPE/1707 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

31.0

Neutral momentum band

Price vs 200-day MA

-9.4%

50/200-day relationship not available

Beta (5Y)

0.26

Less volatile than the market

Sharpe ratio

-1.25

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPE/1707

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/1707 stock rating?

tpe/1707 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/1707 analysis?

The full report lives at /stocks/tpe/1707/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/1707?

The latest report frames tpe/1707 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/1707 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.